Breaking New York City’s “Pied-à-terre” Tax Sparks Debate and Legal Challenges Google Unveils New Pixel Phones With Advanced AI and Enhanced Camera Features Key 2026 College Football Matchups Poised to Shape Playoff Picture Severe Weather Causes Fatalities and Widespread Power Outages Across Midwest Five Car Models Slated for Discontinuation After 2026 Model Year, Edmunds Reports

Wednesday August 12, 2026

Reporter

Acurx Pharmaceuticals, Inc.

3Articles Published

4Communities Covered

Published Articles

Press Release

Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics

3 hours ago

Press Release

Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx’s DNA Polymerase IIIC Inhibitor Antibiotics

Aug 10

Press Release

FDA Provides Further Regulatory Guidance to Acurx Pharmaceuticals for the Ibezapolstat Clinical Development Program, Including the Potential for a Single-Phase 3-Trial Registration Plan and a Trial Design to Support Both Treatment and Reduction of Recurrence of C. difficile Infection

Aug 3